Gulo E I, Vinokurov V L, Bokhman Ia V
Vopr Onkol. 1992;38(5):616-23.
Data on 304 patients with ovarian malignancies (mostly epithelial-72.0%) who had undergone second-look surgery were analysed to develop indications and assess the clinical value of the procedure. Second-look operations were performed 10-22 months after primary surgery in the following clinical settings: (1) clinical remission if wash-offs from the Douglas' pouch peritoneum revealed tumor cells or a high blood-CA-125 level was established (8 patients with stage I-II cancer), (2) remission after 6-10 courses of combination chemotherapy (13 patients with stage III-IV tumor), (3) remission following non-radical primary surgery (117 cases), (4) patients with suspected relapse (144), and (5) cases who were not suspicious for relapse but required laparotomy for concomitant surgical pathology such as, for instance, ventral hernia (22). Intra- and postoperative complications were encountered in 29 out of 304 (9.5%) patients and operative lethality rate was 0.9%. It was shown that improvement in noninvasive methods of monitoring allows to limit indications for second-look surgery in stage III cancer.
对304例接受二次探查手术的卵巢恶性肿瘤患者(大多数为上皮性肿瘤,占72.0%)的数据进行分析,以明确手术指征并评估该手术的临床价值。二次探查手术在初次手术后10 - 22个月进行,具体临床情况如下:(1)若Douglas窝腹膜冲洗液发现肿瘤细胞或血CA - 125水平升高(8例Ⅰ - Ⅱ期癌症患者),则为临床缓解;(2)接受6 - 10个疗程联合化疗后的缓解期(13例Ⅲ - Ⅳ期肿瘤患者);(3)初次非根治性手术后的缓解期(117例);(4)疑似复发患者(144例);(5)虽无复发可疑但因伴有外科病理情况(如腹疝)需要行剖腹手术的病例(22例)。304例患者中有29例(9.5%)发生术中及术后并发症,手术致死率为0.9%。结果表明,无创监测方法的改进使得Ⅲ期癌症患者二次探查手术的指征得以限制。